Listen to the article
House Passes Bill Criminalizing Transgender Medical Treatment for Minors in Narrow Vote
In a contentious vote that highlighted deep partisan divides on transgender healthcare issues, the House of Representatives passed legislation Wednesday criminalizing gender-affirming medical treatments for minors. The bill narrowly succeeded with a 216-211 vote that included some notable crossover from both parties.
The legislation creates new federal crimes carrying up to 10 years in prison for doctors who perform gender-affirming surgeries on minors or prescribe puberty blockers. Additionally, parents or guardians who consent to or facilitate such treatments for children under 18 could face criminal liability.
While Republicans largely supported the measure, with 45 House Republicans formally endorsing it prior to the vote, the bill faced significant opposition from Democrats. Three Democratic Representatives—Vicente Gonzales and Henry Cuellar of Texas, along with Don Davis of North Carolina—broke with their party to support the bill. Conversely, four Republicans—Mike Kennedy of Utah, Brian Fitzpatrick of Pennsylvania, Gabe Evans of Colorado, and Mike Lawler of New York—voted against it.
Despite passing in the House, the bill’s future remains uncertain in the GOP-controlled Senate, where leadership has not yet indicated whether they will bring the measure to the floor.
The legislation represents one of the most aggressive federal attempts to restrict transgender healthcare access, coming amid a wave of state-level restrictions across the country. Over the past three years, more than 20 states have enacted laws limiting or banning gender-affirming care for minors, though several face ongoing legal challenges.
Civil rights organizations immediately condemned the bill’s passage. Mike Zamore, National Director of Policy & Government Affairs at the American Civil Liberties Union, called it an “extreme bill” that “puts the threat of prosecution between hundreds of thousands of families and their doctors and would put doctors behind bars for exercising their best medical judgment.”
“Passing this bill would be a grave escalation of an already severe effort to not only push transgender people out of public life but also allow the state to control our bodies and our lives further,” Zamore added.
The vote reflects growing tensions around transgender issues within both major political parties. While most Democrats oppose such restrictions, viewing them as discriminatory and interfering with healthcare decisions best left to families and medical professionals, Republicans have increasingly embraced restrictions on gender-affirming care as a key cultural and political priority.
Rep. Nancy Mace (R-S.C.), a vocal supporter of the legislation, delivered pointed remarks on the House floor, saying, “It is obscene. It is disgusting. You’re seeing in real time Democrats wanting and defending grooming of children. And it is abhorrent.” She added, “There is a lie at the heart of the debate we’re having today that I have to correct—no child is born in the wrong body. There are only two sexes, male and female. There are no others.”
The bill comes during an election year when transgender rights have become increasingly politicized. Major medical organizations, including the American Academy of Pediatrics and the American Medical Association, oppose blanket bans on gender-affirming care, arguing they interfere with the physician-patient relationship and contradict evidence-based medical practices.
If the bill advances to the Senate, it would likely face stronger opposition, including potential filibuster from Democrats. President Biden has already signaled he would veto such legislation if it reached his desk, describing these restrictions as harmful to transgender youth and their families.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.


23 Comments
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on House Democrats Oppose Bill to Criminalize Transgender Surgeries for Minors. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.